Ventripoint Diagnostics Ltd. (TSXV:VPT)
Canada · Delayed Price · Currency is CAD 0.1050
0.00 (0.00%)
At close: Feb 27, 2026
Ventripoint Diagnostics Market Cap
Ventripoint Diagnostics has a market cap or net worth of CAD 19.6 million as of March 2, 2026. Its market cap has increased by 34.26% in one year.
Market Cap
19.60M
Enterprise Value
21.88M
Revenue
175.62K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since September 21, 2007, Ventripoint Diagnostics's market cap has increased from 6.82M to 19.60M, an increase of 187.18%. That is a compound annual growth rate of 5.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 19.60M | -16.80% |
| Dec 31, 2025 | 23.56M | 45.40% |
| Dec 31, 2024 | 16.20M | -64.98% |
| Dec 29, 2023 | 46.26M | 9.26% |
| Dec 30, 2022 | 42.34M | -21.10% |
| Dec 31, 2021 | 53.67M | 567.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theralase Technologies | 75.53M |
| Cannabix Technologies | 68.59M |
| Perimeter Medical Imaging AI | 39.34M |
| Conavi Medical | 38.26M |
| Cheelcare | 35.57M |
| Aurora Spine | 20.52M |
| MedX Health | 18.04M |
| VVT Med | 17.74M |